Comparison of survival outcomes in haemodialysis versus immediate‐start peritoneal dialysis: A propensity‐matched study
Nephrology · 2025
DOI: 10.1111/nep.14418 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nephrology, 2025. Verfasst von Jee Young Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic, Propensity Score, Renal Dialysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Konkuk University Medical Center.
Abstract (Originalsprache)
Aim
Recent reports suggest that immediate‐start peritoneal dialysis (ISPD) initiated immediately after catheter insertion demonstrates better long‐term outcomes. However, the survival rate of ISPD versus haemodialysis (HD) remains uncertain. This study aimed to compare survival rates between ISPD and HD using a matched‐pair cohort.
Methods
We retrospectively reviewed the medical records of 911 patients with end‐stage kidney disease (ESKD) who received HD or peritoneal dialysis at our centre between August 2005 and September 2023. After 1:1 propensity score matching between ISPD and HD patients, we calculated survival rates using Kaplan–Meier analysis and identified the influencing factors with multivariate Cox regression.
Results
In this cohort of 911 patients, ISPD and HD groups included 162 and 676 patients respectively. After 1:1 propensity matching 140 patients on ISPD were matched with 140 patients on HD. The 1‐, 2‐, 3‐, 4‐, and 5‐year survival rates were 98.5%, 93.6%, 92.5%, 91.1%, and 91.1% for ISPD, and 96.3%, 93.0%, 90.4%, 87.2%, and 83.3% for HD groups (log‐rank p = 0.17). The survival rates were comparable between the groups. However, in the non‐diabetic population, patients on ISPD showed significantly higher survival rates than those on HD (log‐rank p = .03). Diabetes was an independent risk factor for mortality in the ISPD group according to multivariate Cox regression.
Conclusion
Long‐term survival rates were comparable between ISPD and HD groups. The survival benefit was more pronounced in the non‐diabetic population. These results suggest that ISPD may be a better renal replacement therapy option than HD, particularly for the non‐diabetic ESKD population in terms of patient survival. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Jee Young Lee, Young-Il Jo
Förderung
- Konkuk University Medical Center
Zitieren
APA
Lee, J. Y., Cho, H., Park, J. H., & Jo, Y. I. (2025). Comparison of survival outcomes in haemodialysis versus immediate‐start peritoneal dialysis: A propensity‐matched study. Nephrology. https://doi.org/10.1111/nep.14418
Vancouver
Lee JY, Cho H, Park JH, Jo YI. Comparison of survival outcomes in haemodialysis versus immediate‐start peritoneal dialysis: A propensity‐matched study. Nephrology. 2025. doi:10.1111/nep.14418
BibTeX
@article{Lee2025,
author = {Lee, Jee Young and Cho, Hyunjin and Park, Jung-Hwan and Jo, Young-Il},
title = {Comparison of survival outcomes in haemodialysis versus immediate‐start peritoneal dialysis: A propensity‐matched study},
journal = {Nephrology},
year = {2025},
doi = {10.1111/nep.14418}
}
EUVIMED